Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $286,341 | 170 | 99.3% |
| Travel and Lodging | $1,966 | 12 | 0.7% |
| Food and Beverage | $14.69 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $216,368 | 133 | $0 (2024) |
| Shire North American Group Inc | $71,939 | 49 | $0 (2019) |
| Zimmer Biomet Holdings, Inc. | $14.69 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,928 | 28 | Takeda Pharmaceuticals U.S.A., Inc. ($50,928) |
| 2023 | $32,104 | 20 | Takeda Pharmaceuticals U.S.A., Inc. ($32,104) |
| 2022 | $44,264 | 28 | Takeda Pharmaceuticals U.S.A., Inc. ($44,264) |
| 2021 | $43,136 | 27 | Takeda Pharmaceuticals U.S.A., Inc. ($43,136) |
| 2020 | $45,950 | 31 | Takeda Pharmaceuticals U.S.A., Inc. ($45,936) |
| 2019 | $34,873 | 24 | Shire North American Group Inc ($34,873) |
| 2018 | $17,600 | 10 | Shire North American Group Inc ($17,600) |
| 2017 | $19,466 | 15 | Shire North American Group Inc ($19,466) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,375.00 | General |
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $102.64 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 07/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 07/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
About Dr. Robert Marsh, MD
Dr. Robert Marsh, MD is a Family Medicine healthcare provider based in Minnetonka, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659428019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Marsh, MD has received a total of $288,321 in payments from pharmaceutical and medical device companies, with $50,928 received in 2024. These payments were reported across 183 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($286,341).
Practice Information
- Specialty Family Medicine
- Location Minnetonka, MN
- Active Since 01/05/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659428019
Products in Payments
- MS (Device) $14.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Minnetonka
Melika Abdulwhab
Family Medicine — Payments: $165.65
Dr. Zubair Ali, M.d, M.D
Family Medicine — Payments: $118.55
Mark Stevenson, Md, Mph, MD, MPH
Family Medicine — Payments: $113.16
Brian Henjum, Md, MD
Family Medicine — Payments: $97.12
Timothy Pryor
Family Medicine — Payments: $17.46
Halbert Wenngatz, Md, MD
Family Medicine